Trade Desk ceiling keeps getting higher

The Trade Desk continues its ascent towards the $1,000 mark, as the torrid stock closed at $890.13 Dec. 1—up 516% since its year low in mid-March.
Read More →Semtech reaches record highs after earnings beat

Semtech, a Camarillo semiconductor company specializing in Internet of Things applications, announced earnings on Dec. 2 that beat both the previous quarter and analysts’ estimates. Shares of Semtech were trading at just under $70 my midday on Dec. 3, the highest stock price in the company’s history. The company’s shares are up 23% in the Read More →
Read More →
PureSpectrum headlines region’s companies on Deloitte’s Fast 500
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →
Gig companies benefit from ballot measure
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen joins new cooperative trials for COVID treatment

With COVID-19 continuing to surge across the globe, a coalition of pharmaceutical companies including Thousand Oaks-based Amgen has announced a joint trial for new coronavirus treatments. Amgen, along with Takeda and UCB, are now collaborating to study methods of treatment for patients who are hospitalized due to COVID-19, the three companies announced. The trial enrolled Read More →
Read More →